These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Roles of mutant p53 gene in malignant phenotypes and resistance to drugs in anti-7,8-dihydrodiol-9,10-epoxide benzo(a)pyrene-induced lung cancer cells].
    Author: Du CH, Xu J, Zhong NS.
    Journal: Zhonghua Jie He He Hu Xi Za Zhi; 2005 Mar; 28(3):176-9. PubMed ID: 15854413.
    Abstract:
    OBJECTIVE: To study the role of mutant p53 gene induced by anti-7,8-dihydrodiol-9,10-epoxide benzo(a)pyrene (BPDE) in the development of lung cancer and the effects of wild-type p53 substitution on malignant phenotype and resistance to drugs. METHODS: BPDE-induced human lung cancer cells (16HBE, a human bronchial epithelial cell line, treated by BPDE) with mutant p53 gene were transfected with pShuttle-cmv-wild p53, followed by soft-agar colony formation assay and cell growth assay. Genome DNAs were extracted from those cells after transfection for detection of apoptosis. Sensitivity of the cells to drugs was also detected simultaneously. RESULTS: It was shown that exogenous wild-type p53 transfection inhibited colony formation of the lung cancer cells with mutant p53 gene and induced cell growth arrest and cell apoptosis. In addition, the lung cancer cells transfected with wild-type p53 gene showed enhanced sensitivity to adriamycin (ADM) to which the cells before transfection was resistant. CONCLUSIONS: p53 mutation plays an important role in the development and progress of lung cancer, as well as in multi-drug resistance in the management of lung cancer chemotherapy. Wild-type p53 substitution therapy may enhance the sensitivity of lung cancer to chemical drugs.
    [Abstract] [Full Text] [Related] [New Search]